Skip to main content

Table 3 Biopsy-proven acute rejection rate (BPAR)

From: Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients

Group

n in group

Total BPAR

CI-BPAR

PB-BPAR

n

%

n

%

n

%

 Low-risk

218

33

15.1

21

9.6

12

5.5

 High-risk

72

10

13.9

8

11.1

2

2.8

 

Low-risk

High-risk

 

Donor type

n in group

BPAR

n in group

BPAR

 

n

%

n

%

 

 Living

88

17

19.3

38

6

15.8

 

 DBD

91

10

11

30

3

10

 

 DCD

39

6

15.4

4

1

25

 
  1. Abbreviations: BPAR Biopsy-proven acute rejection, CI-BPAR Clinically-indicated BPAR, Protocol biopsy identified BPAR, DBD Donation after brain death, DCD Donation after Circulatory death